| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |